|
C6ORF62 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.899700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.032600E-01 |
| Normal-vs-Stage2 |
4.474000E-02 |
| Normal-vs-Stage3 |
1.234190E-02 |
| Normal-vs-Stage4 |
2.290200E-02 |
| Stage1-vs-Stage2 |
9.386000E-02 |
| Stage1-vs-Stage3 |
1.325920E-02 |
| Stage1-vs-Stage4 |
6.074000E-02 |
| Stage2-vs-Stage3 |
8.991200E-01 |
| Stage2-vs-Stage4 |
9.190000E-01 |
| Stage3-vs-Stage4 |
9.904000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.406250E-01 |
| Normal-vs-AfricanAmerican |
6.509400E-01 |
| Normal-vs-Asian |
5.957600E-01 |
| Caucasian-vs-AfricanAmerican |
5.879000E-01 |
| Caucasian-vs-Asian |
2.417600E-01 |
| AfricanAmerican-vs-Asian |
9.338800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.394560E-01 |
| Normal-vs-Female |
8.026100E-02 |
| Male-vs-Female |
9.222400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.121800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.447700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.044940E-03 |
| Normal-vs-Age(81-100Yrs) |
2.585600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.070000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.615050E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.985000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.772300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.666600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.266200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.275700E-02 |
| Classical-VS-Follicular |
1.69661999999127E-05 |
| Classical-VS-Other |
5.584800E-01 |
| Classical-VS-Normal |
8.081000E-01 |
| Tall-VS-Follicular |
4.140400E-01 |
| Tall-VS-Other |
6.129600E-01 |
| Tall-VS-Normal |
3.394300E-02 |
| Follicular-VS-Other |
3.573400E-01 |
| Follicular-VS-Normal |
3.192600E-04 |
| Other-VS-Normal |
4.979200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.708400E-02 |
| Normal-vs-N1 |
4.769800E-02 |
| N0-vs-N1 |
8.686000E-01 |
|
|
